Last 12 months
Inside the activity.
2 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2021 Filed Feb 4, 2022 22:35 UTC Amendment |
Christianson MarkBusiness Development Director
|
SaleCommon Stock | 11,300 | $6.74 | $76,200.42 |
DisclosureSEC source: 0001709738-22-000001 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,769 F1 · price: The price reported in Column 4 is a weighted average price. These shares of the issuer's common stock were sold in multiple transactions at prices ranging from $6.50 to $6.97, inclusive. The reporting person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. F2 · balance_after: This amendment is being filed to correct the number of shares beneficially owned by the reporting person following the reported transaction. The issuer effected a one-for-three reverse stock split of shares of its common stock on March 31, 2021, and the total number of shares held by the reporting person has been corrected to adjust for the split. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:29 UTC |
MATHIESEN JEFFREY SDirector
|
GrantOption to Purchase Common Stock · Derivative | 4,682 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001596771-21-000039 · primary_doc.xml · derivative · entry 2 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,682 Underlying: Common Stock · 4,682 shares Expires 2031-06-02 F3 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:29 UTC |
MATHIESEN JEFFREY SDirector
|
GrantCommon Stock | 4,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-21-000039 · primary_doc.xml · nonDerivative · entry 1 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,811 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. F2 · balance_after: The share amount has been adjusted to reflect the reverse stock split effective on March 31, 2021 whereby each three shares issued and outstanding prior to the split were combined and converted into one share of common stock. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:18 UTC |
BUCKMAN PAULDirector
|
GrantOption to Purchase Common Stock · Derivative | 4,682 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001596771-21-000038 · primary_doc.xml · derivative · entry 2 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,682 Underlying: Common Stock · 4,682 shares Expires 2031-06-02 F3 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:18 UTC |
BUCKMAN PAULDirector
|
GrantCommon Stock | 4,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-21-000038 · primary_doc.xml · nonDerivative · entry 1 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,424 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. F2 · balance_after: The share amount has been adjusted to reflect the reverse stock split effective on March 31, 2021 whereby each three shares of common stock issued and outstanding prior to the split were combined and converted into one share of common stock. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:06 UTC |
Andrle EdwardDirector
|
GrantOption to Purchase Common Stock · Derivative | 4,682 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001596771-21-000037 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,682 Underlying: Common Stock · 4,682 shares Expires 2031-06-02 F3 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:06 UTC |
Andrle EdwardDirector
|
GrantCommon Stock | 4,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-21-000037 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,404 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. F2 · balance_after: The share amount has been adjusted to reflect the reverse stock split effective on March 31, 2021 whereby each three shares of common stock issued and outstanding prior to the split were combined and converted into one share of common stock. Read SEC document |
| May 26, 2021 Filed Oct 7, 2021 20:03 UTC |
Rosa David ADirector · CEO and President
|
GrantOption to Purchase Common Stock · Derivative | 83,333 | $0.00 Strike: $5.97 | $0.00 |
DisclosureSEC source: 0001540354-21-000001 · primary_doc.xml · derivative · entry 1 Rosa David A · CIK 0001540354 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,667 Underlying: Common Stock · 83,333 shares Expires 2031-01-27 F1 · derivative.exercise_date: On January 27, 2021, the reporting person was granted an option to purchase shares of common stock, 83,333 shares of which were subject to performance criteria, which performance criteria were met on May 26, 2021, resulting in the vesting of that portion of the option. Read SEC document |
| April 26, 2021 Filed Apr 28, 2021 18:13 UTC |
Haris HijazVP of Marketing
|
GrantOption to Purchase Common Stock · Derivative | 60,000 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001859325-21-000002 · primary_doc.xml · derivative · entry 1 Haris Hijaz · CIK 0001859325 · VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: 25% will vest on April 26, 2022 and the remaining 75% will vest in 36 equal monthly installments beginning on May 31, 2022. Read SEC document |
| January 27, 2021 Filed Jan 29, 2021 22:10 UTC |
McClurg Ronald W.Chief Financial Officer
|
GrantOption to Purchase Common Stock · Derivative | 140,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001596771-21-000007 · primary_doc.xml · derivative · entry 1 McClurg Ronald W. · CIK 0001837830 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-01-27 F1 · derivative.exercise_date: 25% will vest on January 27, 2022 and remaining 75% will vest in 36 equal monthly installments on the last day of each month beginning on February 28, 2022. Read SEC document |
| January 27, 2021 Filed Jan 29, 2021 21:59 UTC |
Mertens SteveChief Technology Officer
|
GrantOption to Purchase Common Stock · Derivative | 70,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001596771-21-000006 · primary_doc.xml · derivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-01-27 F1 · derivative.exercise_date: 25% will vest on January 27, 2022 and the remaining 75% will vest in 36 equal monthly installments on the last day of each month beginning on February 28, 2022. Read SEC document |
| January 27, 2021 Filed Jan 29, 2021 21:49 UTC |
Rosa David ADirector · CEO and President
|
GrantOption to Purchase Common Stock · Derivative | 1,000,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001596771-21-000005 · primary_doc.xml · derivative · entry 1 Rosa David A · CIK 0001540354 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2031-01-27 F1 · derivative.exercise_date: 25% will vest on January 27, 2022 and the remaining will vest in 36 equal monthly installments on the last day of each month beginning on February 28, 2022. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 19:41 UTC |
McClurg Ronald W.Chief Financial Officer
|
GrantOption to Purchase Common Stock · Derivative | 180,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001213900-21-000388 · ownership.xml · derivative · entry 1 McClurg Ronald W. · CIK 0001837830 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: 25% will vest on January 1, 2022 and the remaining 75% will vest in 36 equal monthly installments beginning on February 1, 2022. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 19:12 UTC |
MATHIESEN JEFFREY SDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 34,020 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001596771-20-000053 · primary_doc.xml · derivative · entry 2 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,020 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 19:12 UTC |
MATHIESEN JEFFREY SDirector
|
Exercise / conversionCommon Stock | 34,020 | $0.04 | $1,190.70 |
DisclosureSEC source: 0001596771-20-000053 · primary_doc.xml · nonDerivative · entry 1 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 18:38 UTC |
Christianson MarkVP of Market Development
|
SaleCommon Stock | 334,000 | $0.60 | $200,400.00 |
DisclosureSEC source: 0001596771-20-000052 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · VP of Market Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,089,206 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:27 UTC |
MATHIESEN JEFFREY SDirector
|
GrantOption to Purchase Common Stock · Derivative | 23,725 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001596771-20-000047 · primary_doc.xml · derivative · entry 2 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,725 Underlying: Common Stock · 23,725 shares Expires 2030-06-02 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:27 UTC |
MATHIESEN JEFFREY SDirector
|
GrantCommon Stock | 22,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000047 · primary_doc.xml · nonDerivative · entry 1 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,638 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:17 UTC |
BUCKMAN PAULDirector
|
GrantOption to Purchase Common Stock · Derivative | 23,725 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001596771-20-000046 · primary_doc.xml · derivative · entry 2 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,725 Underlying: Common Stock · 23,725 shares Expires 2030-06-02 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:17 UTC |
BUCKMAN PAULDirector
|
GrantCommon Stock | 22,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000046 · primary_doc.xml · nonDerivative · entry 1 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,495 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:07 UTC |
Andrle EdwardDirector
|
GrantOption to Purchase Common Stock · Derivative | 23,725 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001596771-20-000045 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,725 Underlying: Common Stock · 23,725 shares Expires 2030-06-02 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:07 UTC |
Andrle EdwardDirector
|
GrantCommon Stock | 22,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000045 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,435 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:55 UTC |
Andrle EdwardDirector
|
GrantCommon Stock | 7,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000008 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,064 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:45 UTC |
MATHIESEN JEFFREY SDirector
|
GrantCommon Stock | 26,261 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000003 · primary_doc.xml · nonDerivative · entry 1 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,267 F1 · shares: Represents a grant of restricted stock units, which were fully vested on the date of grant. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:36 UTC |
BUCKMAN PAULDirector
|
GrantCommon Stock | 44,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000002 · primary_doc.xml · nonDerivative · entry 1 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,124 F1 · shares: Represents a grant of restricted stock units, which were fully vested on the date of grant. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 21:12 UTC |
Kalia SurajDirector
|
GrantOption to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001596771-19-000132 · primary_doc.xml · derivative · entry 1 Kalia Suraj · CIK 0001709984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-11-05 Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 21:32 UTC |
Rosa David ADirector · CEO and President
|
GrantOption to Purchase Common Stock · Derivative | 500,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001596771-19-000134 · primary_doc.xml · derivative · entry 1 Rosa David A · CIK 0001540354 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2029-11-05 F1 · derivative.exercise_date: 25% will vest on November 5, 2020 and the remaining 75% will vest in 36 equal monthly installments beginning on December 1, 2020. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 21:22 UTC |
MATHIESEN JEFFREY SDirector
|
GrantOption to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001596771-19-000133 · primary_doc.xml · derivative · entry 1 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-11-05 Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 21:04 UTC |
BUCKMAN PAULDirector
|
GrantOption to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001596771-19-000131 · primary_doc.xml · derivative · entry 1 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-11-05 Read SEC document |
| October 21, 2019 Filed Oct 23, 2019 16:11 UTC |
Fredrickson Wade10% owner
|
OtherCommon Stock | 500,000 | $1.00 | $500,000.00 |
DisclosureSEC source: 0001104659-19-055755 · tm1920765d1_4.xml · nonDerivative · entry 1 Fredrickson Wade · CIK 0001709644 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,113,459 F1 · kind: Reporting Person sold the referenced securities in a privately negotiated transaction. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 23:05 UTC |
MATHIESEN JEFFREY SDirector
|
GrantOption to Purchase Common Stock · Derivative | 14,995 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000062 · primary_doc.xml · derivative · entry 2 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,995 Underlying: Common Stock · 14,995 shares Expires 2029-06-04 F2 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 23:05 UTC |
MATHIESEN JEFFREY SDirector
|
GrantCommon Stock | 14,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-19-000062 · primary_doc.xml · nonDerivative · entry 1 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,006 F1 · shares: Represents a grant of restricted stock units. Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the shares will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:54 UTC |
Kalia SurajDirector
|
GrantOption to Purchase Common Stock · Derivative | 14,995 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000061 · primary_doc.xml · derivative · entry 2 Kalia Suraj · CIK 0001709984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,995 Underlying: Common Stock · 14,995 shares Expires 2029-06-04 F2 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:54 UTC |
Kalia SurajDirector
|
GrantCommon Stock | 14,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-19-000061 · primary_doc.xml · nonDerivative · entry 1 Kalia Suraj · CIK 0001709984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,006 F1 · shares: Represents a grant of restricted stock units. Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the shares will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:43 UTC |
BUCKMAN PAULDirector
|
GrantOption to Purchase Common Stock · Derivative | 14,995 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000060 · primary_doc.xml · derivative · entry 2 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,995 Underlying: Common Stock · 14,995 shares Expires 2029-06-04 F2 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:43 UTC |
BUCKMAN PAULDirector
|
GrantCommon Stock | 14,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-19-000060 · primary_doc.xml · nonDerivative · entry 1 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,006 F1 · shares: Represents a grant of restricted stock units. Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the shares will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:33 UTC |
MATHIESEN JEFFREY SDirector
|
GrantOption to Purchase Common Stock · Derivative | 45,605 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000044 · primary_doc.xml · derivative · entry 1 MATHIESEN JEFFREY S · CIK 0001296853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,605 Underlying: Common Stock · 45,605 shares Expires 2029-05-13 Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:23 UTC |
Kalia SurajDirector
|
GrantOption to Purchase Common Stock · Derivative | 45,605 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000043 · primary_doc.xml · derivative · entry 1 Kalia Suraj · CIK 0001709984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,605 Underlying: Common Stock · 45,605 shares Expires 2029-05-13 Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:14 UTC |
BUCKMAN PAULDirector
|
GrantOption to Purchase Common Stock · Derivative | 45,605 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000042 · primary_doc.xml · derivative · entry 1 BUCKMAN PAUL · CIK 0001215243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,605 Underlying: Common Stock · 45,605 shares Expires 2029-05-13 Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:04 UTC |
Mertens SteveChief Technology Officer
|
GrantOption to Purchase Common Stock · Derivative | 129,445 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000041 · primary_doc.xml · derivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,445 Underlying: Common Stock · 129,445 shares Expires 2029-05-13 F1 · derivative.exercise_date: The options were granted on May 13, 2019. 32,361 options immediately vested on the grant date, and the remaining options will vest in 36 equal monthly installments beginning on April 1, 2020. Read SEC document |
| April 03, 2019 Filed Apr 4, 2019 16:30 UTC | OtherCommon Stock, Par value $0.001 | 287,130 | $4.25 | $1,220,302.50 |
DisclosureSEC source: 0000899243-19-009986 · doc4.xml · nonDerivative · entry 1 MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH · CIK 0000897680 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,846 F1 · kind: The Reporting Person transferred the shares to several individuals in satisfaction of certain contractual obligations. The price of $4.25 per share represents the recent market price of a share of common stock at the time of transfer. F1 · price: The Reporting Person transferred the shares to several individuals in satisfaction of certain contractual obligations. The price of $4.25 per share represents the recent market price of a share of common stock at the time of transfer. F2 · ownership.direct: Mayo Clinic, a Minnesota corporation ("Mayo"), is the controlling corporation of the Reporting Person and is referenced here solely due to its control of the Reporting Person. Mayo disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mayo is the beneficial owner of the securities for purposes of Section 16 or any other purpose. Read SEC document |
|
| January 01, 2019 Filed Mar 1, 2019 22:22 UTC |
Heuler ScottVice President of Sales
|
GrantOption to Purchase Common Stock · Derivative | 100,365 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001596771-19-000016 · primary_doc.xml · derivative · entry 1 Heuler Scott · CIK 0001763425 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,365 Underlying: Common Stock · 100,365 shares Expires 2029-01-01 F1 · derivative.exercise_price: On February 27, 2019, the Board of Directors of the Issuer determined that the fair market value of the Company's common stock as of January 1, 2019 was $2.20 per share. F2 · derivative.exercise_date: 25% of the options were immediately exercisable, and the remaining options will vest in 36 equal monthly installments beginning on January 1, 2020. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:08 UTC |
Fredrickson Wade10% owner
|
SaleCommon Stock | 227,272 | $1.10 | $249,999.20 |
DisclosureSEC source: 0001144204-18-012771 · tv487738_4.xml · nonDerivative · entry 1 Fredrickson Wade · CIK 0001709644 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,613,459 F1 · kind: Privately negotiated sale. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 20:02 UTC |
Christianson MarkVP, Business Dev and Marketing · 10% owner
|
GrantCommon Stock | 1,423,206 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001596771-17-000063 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · VP, Business Dev and Marketing · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,423,206 F1 · price: The reporting person acquired the shares of NeuroOne Medical Technologies Corporation ("NMTC") on July 20, 2017, in exchange for shares of the common stock of NeuroOne, Inc. ("NeuroOne"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of July 20, 2017, between NMTC, OSOK Acquisition Company and NeuroOne, pursuant to which NeuroOne became the wholly-owned subsidiary of NMTC. Per the terms of the Merger Agreement, each share of NeuroOne common stock was converted into the right to receive 17.0103706 shares of NMTC common stock. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 20:28 UTC |
Rosa David ADirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 793,822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001596771-17-000064 · primary_doc.xml · nonDerivative · entry 1 Rosa David A · CIK 0001540354 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 793,822 F1 · price: The reporting person acquired the shares of NeuroOne Medical Technologies Corporation ("NMTC") on July 20, 2017, in exchange for shares of common stock of NeuroOne, Inc. ("NeuroOne"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of July 20, 2017, between NMTC, OSOK Acquisition Company and NeuroOne, pursuant to which NeuroOne became the wholly-owned subsidiary of NMTC. Per the terms of the Merger Agreement, each share of NeuroOne common stock was converted into the right to receive 17.0103706 shares of NMTC common stock. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 19:52 UTC |
Bachinski ThomasChief Development Officer
|
GrantCommon Stock | 215,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001596771-17-000062 · primary_doc.xml · nonDerivative · entry 1 Bachinski Thomas · CIK 0001710364 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,453 F1 · price: The reporting person acquired the shares of NeuroOne Medical Technologies Corporation ("NMTC") on July 20, 2017, in exchange for shares of the common stock of NeuroOne, Inc. ("NeuroOne"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of July 20, 2017, between NMTC, OSOK Acquisition Company and NeuroOne, pursuant to which NeuroOne became a wholly-owned subsidiary of NMTC. Per the terms of the Merger Agreement, each share of NeuroOne common stock was converted into the right to receive 17.0103706 shares of NMTC common stock. Read SEC document |
| July 20, 2017 Filed Aug 7, 2017 18:26 UTC |
Samad AmerDirector
|
OtherCommon Stock | 3,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001009448-17-000036 · primary_doc.xml · nonDerivative · entry 1 Samad Amer · CIK 0001606579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,728 Read SEC document |
| May 19, 2017 Filed Jul 14, 2017 13:03 UTC |
Samad AmerDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 15,728 | $0.03 | $501.72 |
DisclosureSEC source: 0001009448-17-000032 · primary_doc.xml · nonDerivative · entry 1 Samad Amer · CIK 0001606579 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,515,728 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.